| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 8.797 | 62.566 | 0 | 402.977 | 0 |
| Total Income - EUR | - | - | - | - | - | 8.797 | 62.566 | 0 | 402.977 | 3.228 |
| Total Expenses - EUR | - | - | - | - | - | 7.022 | 605 | 363 | 7.786 | 769 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 1.774 | 61.961 | -363 | 395.191 | 2.459 |
| Net Profit/Loss - EUR | - | - | - | - | - | 1.510 | 60.084 | -363 | 391.242 | 2.125 |
| Employees | - | - | - | - | - | 1 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Onco Surg Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 8.921 | 68.627 | 6.805 | 406.130 | 196.148 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 0 | 291.818 | 180.994 |
| Cash | - | - | - | - | - | 8.921 | 68.627 | 6.805 | 13.230 | 15.154 |
| Shareholders Funds | - | - | - | - | - | 3.571 | 63.576 | 1.738 | 392.882 | 196.148 |
| Social Capital | - | - | - | - | - | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | - | - | - | - | - | 5.349 | 5.051 | 5.066 | 13.248 | 0 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Onco Surg Medical S.r.l.